Publications

Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients  (2022)

Authors:
Karteri, Sofia; Bruna, Jordi; Argyriou, Andreas A; Mariotto, Sara; Velasco, Roser; Alemany, Montse; Kalofonou, Foteini; Alberti, Paola; Dinoto, Alessandro; Velissaris, Dimitrios; Stradella, Agostina; Cavaletti, Guido; Ferrari, Sergio; Kalofonos, Haralabos P
Title:
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients
Year:
2022
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
A Stampa
Referee:
Name of journal:
Journal of the peripheral nervous system
ISSN of journal:
1085-9489
N° Volume:
27
Number or Folder:
2
Page numbers:
166-174
Keyword:
biomarker, prediction; chemotherapy-induced peripheral neurotoxicity; paclitaxel; serum neurofilament light chain
Short description of contents:
Our aim was to assess the significance of measuring serum neurofilament light chain (sNfL) levels as biomarker of paclitaxel-induced peripheral neurotoxicity (PIPN). We longitudinally measured sNfL in breast cancer patients, scheduled to receive the 12-weekly paclitaxel-based regimen. Patients were clinically examined by means of the Total Neuropathy Score-clinical version (TNSc), while sNfL were quantified, using the highly-sensitive Simoa technique, before starting chemotherapy (Baseline), after 2 (week-2) and 3 (week-3) weekly courses, and at the end of chemotherapy (week-12). Among 59 included patients (mean age: 53.1±11.5 years), 33 (56%) developed grade 0-1 and 26 (44%) grade 2-3 PIPN at week-12. A significant longitudinal increase of sNfL levels from baseline to week-12 was determined, whereas patients wth TNSc grade 2-3 PIPN had significantly increased sNfL levels at week-12, compared to those with grade 0-1. ROC analysis defined a value of NfL of >85 pg/mL at week-3 as the best discriminative determination to predict the development of grade 2-3 PIPN at week-12 (sensitivity 46.2%, specificity 84.8%). The logistic binary regression analysis revealed that age >50 years and the cutoff of >85 pg/mL of sNfL levels at week-3 independently predicted the development of grade 2-3 PIPN at week-12 with a sensitivity of 46%, a specificity of 91%, and a positive and negative predictive values of 75% and 67%, respectively. sNfL levels seem to be a valuable biomarker of neuro-axonal injury in PIPN. Early increase of this biomarker after a 3 weekly chemotherapy course can be a predictive marker of final PIPN severity. This article is protected by copyright. All rights reserved.
Web page:
https://doi.org/10.1111/jns.12493
Product ID:
125690
Handle IRIS:
11562/1061398
Last Modified:
November 29, 2022
Bibliographic citation:
Karteri, Sofia; Bruna, Jordi; Argyriou, Andreas A; Mariotto, Sara; Velasco, Roser; Alemany, Montse; Kalofonou, Foteini; Alberti, Paola; Dinoto, Alessandro; Velissaris, Dimitrios; Stradella, Agostina; Cavaletti, Guido; Ferrari, Sergio; Kalofonos, Haralabos P, Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients «Journal of the peripheral nervous system» , vol. 27 , n. 22022pp. 166-174

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share